What you should know:
– OMNY Health, the leading healthcare ecosystem known for facilitating compliant cross-industry data sharing, launched its platform designed to power AI-driven healthtech companies, furthering the company’s commitment to democratizing health data.
– QuantHealth and ArisGlobal are just two of OMNY’s new partners leveraging this new platform to address AI-driven organizational needs. OMNY Health’s data network uniquely addresses the generative AI need for large, anonymized structured and unstructured electronic medical record (EMR) datasets across diverse provider and patient populations, further emphasizing that the platform provides the data infrastructure and rails for provider organizations to collaborate and fuel the development and use of effective AI solutions to advance healthcare.
Advancing Healthcare with AI: OMNY Health’s Strategic Partnerships
OMNY Health™ is revolutionizing the healthcare landscape with its national data ecosystem, designed to power partnerships that improve clinical outcomes and enhance patient care. Spanning all fifty states and more than 75 million patient lives, the platform connects health systems, specialty health networks, academic medical centers and integrated delivery networks. By facilitating data sharing and research collaboration, OMNY Health drives innovation where patients need it most.
A perfect example of OMNY Health’s impact is its collaboration with QuantHealth and ArisGlobal, two AI-driven partners making significant strides in advancing healthcare. QuantHealth, the leading AI-driven clinical trial design company, uses a vast dataset of 350 million patients to improve clinical trial timelines, mitigate risk, and identify populations likely to respond to treatments. Through OMNY Health’s collaboration, QuantHealth’s pharmaceutical partners can accelerate drug development using simulated clinical trials. This approach provides real-world evidence by predicting clinical trial outcomes, drug efficacy, and patient responses.
ArisGlobal, another key partner, is at the forefront of pharmacovigilance, safety monitoring and reporting systems. With its LifeSphere® technology, ArisGlobal aims to transform safety signal validation and enable comprehensive and proactive signal detection. OMNY Health’s partnership with ArisGlobal demonstrates a commitment to improving healthcare through AI-driven safety monitoring and reporting systems.
These collaborations exemplify OMNY Health’s commitment to accelerating diverse participation in clinical trials and supporting research programs that aim to save lives and improve patient outcomes. The company’s data ecosystem, which reflects more than seven years of historical data and encompasses more than 2 billion clinical notes from more than 300,000 providers across more than 200 specialties, serves as a centralized resource for healthcare and life sciences provider groups. This comprehensive data layer enables health technology companies to drive the next generation of innovation, ensuring patients receive the best possible care.
“Our mission is to liberate data from silos so it can be shared, analyzed, and transformed into life-saving treatments and better patient care,” said Mitesh Rao, CEO of OMNY Health. “Life sciences organizations and providers often face time and budget constraints that hinder their ability to derive insights from their data. Our work on AI-driven platforms can unlock this process by partnering with AI developers who have the data and tools to accelerate breakthrough therapies and monitor new treatments for safety signals to ensure the safety of patient populations.”
